-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Ensysce Biosciences, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q3 2020 to Q3 2024.
- Ensysce Biosciences, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending September 30, 2024 was 9.89M shares, a 221% increase year-over-year.
- Ensysce Biosciences, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 2.26M shares, a 1158% increase from 2022.
- Ensysce Biosciences, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 180K shares, a 99.1% decline from 2021.
- Ensysce Biosciences, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 20.2M shares, a 22.2% increase from 2020.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)